Progress Update on STING Agonists as Vaccine Adjuvants
Low antigen immunogenicity poses a significant challenge in vaccine development, often leading to inadequate immune responses and reduced vaccine efficacy. Therefore, the discovery of potent immune-enhancing adjuvants is crucial. STING (stimulator of interferon genes) agonists are a promising class...
Saved in:
| Main Authors: | Yanru Shen, Weijin Huang, Jianhui Nie, Li Zhang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-03-01
|
| Series: | Vaccines |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2076-393X/13/4/371 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Potential therapeutic strategies for colitis and colon cancer: bidirectional targeting STING pathway
by: Jiaorong Qu, et al.
Published: (2025-01-01) -
Adjunctive beneficial effect of c-di-GMP, a STING agonist, in enhancing protective efficacy of TLR4-adjuvanted tuberculosis subunit vaccine formulations
by: Kee Woong Kwon, et al.
Published: (2025-05-01) -
Conjugated STING agonists
by: Shuhao Qu, et al.
Published: (2025-06-01) -
A Purely Biomanufactured System for Delivering Nanoparticles and STING Agonists
by: Yu‐an Li, et al.
Published: (2025-01-01) -
A lyophilizable LNP vaccine enables STING-reinforced postoperational adjuvant immunotherapy
by: Yi Yang, et al.
Published: (2025-05-01)